medications including isoniazid, rifampin, ethambutol and pyrazinamide at two other hospitals, but showed no apparent improvement. His body weight decreased more than 9 kg in the interim. The patient was otherwise healthy with no underlying disease. He denied drug use and contact with pets or rats. He also denied any history of homosexual contact.
Introduction
Penicilliosis marneffei is a lethal form of systemic fungiosis due to Penicillium marneffei. With its recent upright trend in incidence, the disease has emerged as a serious public health concern in Southeast Asia [1] and its incidence has reached 12.3% in some regions in China. [2] Penicilliosis marneffei is more common in immunocompromised hosts; in Thailand, it ranks third in opportunistic infections behind tuberculosis and cryptococcosis in patients with acquired immunodefi ciency syndrome (AIDS). [3] [4] [5] In Hong Kong, penicilliosis marneffei lags only behind Pneumocystis pneumonia and tuberculosis in immunocompromised hosts. [6] However, it is extremely rare to fi nd systemic Penicillium marneffei infections in immunocompetent persons. Here, we report disseminated penicilliosis marneffei in two immunocompetent hosts.
Case Reports

Case 1
A 37-year-old male patient was admitted because of recurrent episodes of coughing and fever for 1 month. The cough, which started 1 month ago, was irritating and nonproductive. The body temperature reached as high as 40°C. The patient developed night sweats, chest pain, chest tightness, dizziness, headache and pain in both shoulders. He had received antibiotics including ceftriaxone, azithromycin and vancomycin and anti-tuberculosis test, and Candida galactomannan antigen test. Serum mycoplasma pneumonia antibody, anti-tuberculin antibody, anti-legionella antibodies and HIV antibodies were negative. The (1-3)-β-D-glucan content was 500 pg/mL. Sputum smears were negative for acid-fast bacilli and for fungi and sputum cultures were negative for bacteria and fungi.
Two days after admission, the patient suddenly developed spasm of the extremities and convulsions. Cranial MRI showed infective changes in the right parietal lobe, the left frontal lobe and temporal lobe, the meninges, and the diploe [ Figure 3a -d]. In addition, retropharyngeal abscess was noticed on the right at the level of the 2 nd and 3 rd cervical vertebra [ Figure 3e ]. B mode ultrasound revealed a subcutaneous mass in the right shoulder and a mixed echo mass in the bilateral supraclavicular area, but no blood fl ow was detected. Bone marrow biopsy revealed active proliferation of bone marrow cells with an increased ratio of the myeloid to the erythrocytic lineage. The erythrocytic lineage was dominated by mature cells. Many cells with giant segmented nuclei were observed and mature plasma cells were readily observable. Silver and iron staining were negative. Immunohistochemistry revealed that MPO was positive in most cells, CD15, CD20, CD3, CD5, PAX-5, and CD117 were positive in scant cells, CD34 was positive and CK was negative; suggesting reactive bone marrow. Fiberoptic bronchoscopy revealed multiple submucosal nodules in the terminus of the left trachea [ Figure 4a ] and pathological examination showed squamous metaplasia of the epithelia with massive infi ltration by neutrophils, lymphocytes and histiocytes. Yeast-like fungi were observed [ Figure 4b ]. Methylamine silver and PAS staining was positive [ Figure 4c and d], showing ovoid, elliptic and sausage-shaped, septated fungi while AB and acid-fast staining was negative. Biphasic fungal culture of aspirates of the right shoulder mass yielded yeast phase at 35°C with no production of red pigment [ Figure 5a ] and mycelia at 25°C with massive production of red pigment [ Figure 5b ]. Sausage-shaped yeast-like cells with septation were observed under the microscope [ Figure 5c and d], and pulmonary fungal infection with Penicillium marneffei was considered. The fi nal diagnoses were disseminated Penicilliosis marneffei with secondary seizure. The patient was given intravenous amphotericin B liposome for an accumulated dose of 4.15 g, the fever subsided after 5 days and the patient recovered and was discharged from the hospital. However, the patient relapsed after prematurely discontinued prescribed medication without physician permission. The patient was then given oral itraconazole, 20 mL bid for 3 months. At the 3 month follow up, chest CT and head MRI showed resolution of lesion [ Fig. 6a and b].
Case 2
A 32-year-old male was admitted to the hospital on August 15, 2011 because of productive cough for 5 months and subcutaneous mass and fever for 3 months. The patient started coughing 5 months ago with production of whitish sputum. His body temperature reached as high as 39°C, which was most apparent in the afternoon and dusk. Subcutaneous nodules began to appear 3 months ago, which were soft, fl occulating and tender, and yellow-whitish fl uid oozed out when the nodules became ulcerated. Multiple subcutaneous nodules appeared 2 months ago on the chest, abdomen and the extremities. He had received anti-infection and anti-tuberculosis therapy at other hospitals before admission to our hospital, but showed no improvement. His body weight decreased 15 kg in the interim. Physical examination fi ndings were as follows: Body temperature, 37.4°C, pulse, 123/min, respiration, 22/min, and blood pressure, 135/75 mmHg. Multiple generalised subcutaneous nodules were seen on the chest, abdomen and the extremities with purulent secretions. Bilateral lung sounds were clear with no moist rales and rhonchi. 1-3) -β-D-glucan content was <5 pg/ mL. Aspirated purulent smears were negative for acid-fast bacilli. Chest CT revealed enlargement in the hilus and the mediastinum with partial necrosis [ Figure 7 ]. Tracheomediastinal fi stula and purulence and sternum osteomyelitis were considered with oesophageal-mediastinal fi stulae to be excluded. The patient received tentative diagnoses of multiple generalised purulent masses and mediastinal lymph node enlargement with suspected penicilliosis marneffei, non-tuberculous Mycobacterium infection and lymphoma.
Bone marrow smear showed reactive bone marrow: the number of plasma cells was increasd, neutrophil alkaline phosphatase staining, and 100%, NAP score: 368. On August 23, aspirate culture of the purulent nodules yielded fungal mycelia consistent with P. marneffei. The ultimate diagnosis was disseminated Penicilliosis marneffei and the patient was started on intravenous amphotericin B liposome. On the same day, the patient developed septic shock and DIC, and the patient family asked for automatic discharge from the hospital because of economic concerns.
Discussion
Penicillium marneffei is the only known thermally dimorphic species of Penicillium. Yeast phase conidiophores are the infectious form of Penicillium marneffei and are strongly resistant to non-specifi c phagocytosis. Yeast phase cells are pathogenic and cause intracellular infection by adsorption to the epithelial cells in the bronchus. Nittayananta et al. [3] reported that inhalation of conidiophores is the main route of transmission for Penicillium marneffei. Over the recent years, penicilliosis marneffei has seen a steady increase in incidence and is mainly prevalent in Thailand, Indonesia, Malaysia, Laos and Vietnam. In China, it is prevalent in the southern regions, including the provinces of Guangxi and Guangdong, and Hong Kong and Taiwan. [2] [3] [4] [5] [6] In the US and Europe, the disease is mainly seen in patients who have traveled to Southeast Asia. [7] P. marneffei has gradually spread from HIV-infected persons to the general population. Penicilliosis marneffei is also seen increasingly in immunocompetent hosts in China and death is reported in immunocompetent children. [8] This is the fi rst report of an immunocompetent penicilliosis marneffei patient with CNS involvement in China. Dissemination of enicillium marneffei to the CNS has rarely been reported. The 1 st patient in this case report experienced CNS dissemination even though he was found to be HIV. Penicilliosis marneffei is either localised or disseminated. Localised penicilliosis is more commonly seen in skin and subcutaneous infections while the disseminated form more often involves the lungs, liver and lymph nodes. [5] Penicilliosis marneffei in immunocompetent hosts can be manifested as disseminated infection. Patients may have repeated episodes of remitting fever during the course of the illness, giving the false impression that empirical anti-infection or anti-tuberculosis therapy is effective. The two patients in this case report also received empirical anti-infection and anti-tuberculosis therapies at other hospitals and ours before P. marneffei was established as the causative agent of the illness. Furthermore, the manifestations of penicilliosis marneffei in immunocompetent patients are often different those who are immunocompromised. In immunocompetent hosts, focal abscesses, osteolytic destruction, purulent pneumonia and enlargement of the liver, spleen and lymph nodes are typical while they are rarely seen in AIDS patients. The property of growth at 37°C and invasion of blood vessels is a major cause of dissemination and high mortality for the disease. Approximately half of the patients have fungemia, particularly in HIV-positive patients. Penicillium marneffei often invades blood vessels and produces fungal emboli.
The gold standard for diagnosis of penicilliosis marneffei is identifi cation of P. marneffei by fungal culture. Clinical diagnosis of penicilliosis marneffei can be based on the toxic symptoms of patients, increase in leukocyte counts, multiple organ involvement, abscesses of the skin and multiple organs. Rapid diagnosis often relies on identifi cation of septated conidiophores from specimens from skin lesions, blood or bone marrow. Specimens from skin lesions should be taken from the border area between lesions and normal adjacent tissues as central lesions lack blood supply and are often necrotic and specimens from central lesions likely yield false negative results. Because penicillium marneffei grows intracellular, culture after lysis of cells could boost the positive yield.
The onset of penicilliosis marneffei is often subtle and because of its blood vessel invasive property P. marneffei readily spreads to other parts of the body and causes disseminated infections. Early diagnosis and effective antifungal therapy often yield a good clinical outcome. A 2-to 6-week course of intravenous amphotericin B is recommended for those with severe penicilliosis marneffei. Intrathecal administration is not recommended for patients with CNS involvement as intravenous administration is often effective. After the patients are stabilised, they can be switched to oral itraconazole or ketoconazole for 10 weeks. Long-term medication with itraconazole is recommended for patients to avoid relapse of the disease and negative blood or bone marrow culture cannot be bases for discontinuing the medication. The 1 st patient in this case report relapsed after premature termination of medication and intravenous amphotericin B liposome was used.
In conclusion, with the increase in incidence of penicilliosis marneffei in both immunocompromised and immunocompetent hosts, penicilliosis marneffei should be considered in patients with systemic infections and should be aggressively managed with antifungal therapy. 
